The Indus Hospital Blood Center now complies with Federal Drug Association (FDA, USA) requirement for Donor Screening

Since April 2018, Nucleic Acid Testing (NAT) using Polymerase Chain Reaction (PCR) technology is being used for identifying Hepatitis B and Hepatitis C viruses on every single donor in addition to CLIA which was already being performed. Thus fulfilling FDA (USA) requirement for donor screening.